These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32843180)

  • 1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
    Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó;
    Respir Med; 2020; 170():106062. PubMed ID: 32843180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cystic fibrosis constitute an advantage in COVID-19 infection?
    Bezzerri V; Lucca F; Volpi S; Cipolli M
    Ital J Pediatr; 2020 Oct; 46(1):143. PubMed ID: 33023602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sars-CoV-2 infection in patients with cystic fibrosis. An overview.
    Fainardi V; Longo F; Chetta A; Esposito S; Pisi G
    Acta Biomed; 2020 Sep; 91(3):e2020035. PubMed ID: 32921729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spanish registry of Covid-19 screening in asymptomatic pregnants.].
    Encinas Pardilla MB; Caño Aguilar Á; Marcos Puig B; Sanz Lorenzana A; Rodríguez de la Torre I; Hernando López de la Manzanara P; Fernández Bernardo A; Martínez Pérez Ó
    Rev Esp Salud Publica; 2020 Sep; 94():. PubMed ID: 32945290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection in patients on renal replacement therapy. Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN).
    Sánchez-Álvarez JE; Pérez Fontán M; Jiménez Martín C; Blasco Pelícano M; Cabezas Reina CJ; Sevillano Prieto ÁM; Melilli E; Crespo Barrios M; Macía Heras M; Del Pino Y Pino MD
    Nefrologia (Engl Ed); 2020; 40(3):272-278. PubMed ID: 32389518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry.
    Bell S; Campbell J; McDonald J; O'Neill M; Watters C; Buck K; Cousland Z; Findlay M; Lone NI; Metcalfe W; Methven S; Peel R; Almond A; Sanu V; Spalding E; Thomson PC; Mark PB; Traynor JP;
    BMC Nephrol; 2020 Oct; 21(1):419. PubMed ID: 33004002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
    Cosgriff R; Ahern S; Bell SC; Brownlee K; Burgel PR; Byrnes C; Corvol H; Cheng SY; Elbert A; Faro A; Goss CH; Gulmans V; Marshall BC; McKone E; Middleton PG; Ruseckaite R; Stephenson AL; Carr SB;
    J Cyst Fibros; 2020 May; 19(3):355-358. PubMed ID: 32376098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study.
    Thiel SL; Weber MC; Risch L; Wohlwend N; Lung T; Hillmann D; Ritzler M; Risch M; Kohler P; Vernazza P; Kahlert CR; Fleisch F; Cusini A; Karajan TV; Copeland S; Paprotny M
    Swiss Med Wkly; 2020 Oct; 150():w20361. PubMed ID: 33105020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy.
    Scagnolari C; Bitossi C; Frasca F; Viscido A; Oliveto G; Scordio M; De Vito C; Trancassini M; Midulla F; Cimino G; Pierangeli A; Antonelli G
    J Cyst Fibros; 2020 Sep; 19(5):837-838. PubMed ID: 32593510
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
    Wu AHB
    J Appl Lab Med; 2020 Sep; 5(5):1107-1110. PubMed ID: 32609341
    [No Abstract]   [Full Text] [Related]  

  • 11. Pooling for SARS-CoV-2 control in care institutions.
    Cabrera Alvargonzalez JJ; Rey Cao S; Pérez Castro S; Martinez Lamas L; Cores Calvo O; Torres Piñon J; Porteiro Fresco J; Garcia Comesaña J; Regueiro Garcia B
    BMC Infect Dis; 2020 Oct; 20(1):745. PubMed ID: 33046011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics].
    Calvo C; Tagarro A; Otheo E; Epalza C; ;
    An Pediatr (Engl Ed); 2020 Apr; 92(4):239-240. PubMed ID: 32241653
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
    Naehrlich L; Orenti A; Dunlevy F; Kasmi I; Harutyunyan S; Pfleger A; Keegan S; Daneau G; Petrova G; Tješić-Drinković D; Yiallouros P; Bilkova A; Olesen HV; Burgel PR; Parulava T; Diamantea F; Párniczky A; McKone EF; Mei-Zahav M; Salvatore M; Colombo C; Aleksejeva E; Malakauskas K; Schlesser M; Fustik S; Turcu O; Zomer-van Ommen D; Wathne AS; Woźniacki Ł; Pereira L; Pop L; Kashirskaya N; Rodić M; Kayserova H; Krivecs U; Mondejar-Lopez P; de Monestrol I; Dogru D; Makukh H; Cosgriff R; van Koningsbruggen-Rietschel S; Jung A;
    J Cyst Fibros; 2021 Jul; 20(4):566-577. PubMed ID: 34016559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. People power: How India is attempting to slow the coronavirus.
    Vaidyanathan G
    Nature; 2020 Apr; 580(7804):442. PubMed ID: 32286539
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.
    de Ceano-Vivas M; Martín-Espín I; Del Rosal T; Bueno-Barriocanal M; Plata-Gallardo M; Ruiz-Domínguez JA; López-López R; Molina-Gutiérrez MÁ; Bote-Gascón P; González-Bertolín I; García-Sánchez P; Martín-Sánchez J; de Miguel-Lavisier B; Sainz T; Baquero-Artigao F; Méndez-Echevarría A; Calvo C
    Arch Dis Child; 2020 Aug; 105(8):808-809. PubMed ID: 32444450
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of COVID-19 among ophthalmology professionals.
    Lacorzana J; Ortiz-Perez S; Rubio Prats M
    Med Clin (Barc); 2020 Sep; 155(5):225. PubMed ID: 32591177
    [No Abstract]   [Full Text] [Related]  

  • 19. Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
    Jin Y; Yang H; Ji W; Wu W; Chen S; Zhang W; Duan G
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32230900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: A population-based study.
    So H; Mak JW; So J; Lui G; Lun F; Lee J; Chan S; Ho C; Chan JM; Kong SP; Ng WL; Tam LS
    Semin Arthritis Rheum; 2020 Oct; 50(5):885-889. PubMed ID: 32896705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.